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Metabolism and Distribution of Fibrinogen in Young and Older 
Male Rabbits
Thesis directed by Professor E. B. Reeve
This investigation was undertaken to develop methods for
studying and characterizing the behavior of fibrinogen in
healthy animals. For this purpose, two groups, consisting of young
(3 to 5 month) and older (6 to 12 month) rabbits, were selected.
Homologous rabbit fibrinogen 93 to 97 per cent clottable was
prepared by salt fractionation and labeled with I131 -iodide. After
intravenous injection of the -fibrinogen, the animals were
studied for 8 to 10 days. Measurements of the plasma fibrinogen
concentration by isotope dilution revealed fluctuations. Plots of 
131the plasma I -fibrinogen radioactivity against time were fitted by 
a two or three exponential equation. The excretion of the radio­
active breakdown products occurred without delay. A mathematical
model based on both these observations and on current knowledge
131was advanced, and was found to describe the behavior of I.V. I 
fibrinogen. The fractional rate constants were then calculated and 
used to determine the fluxes of fibrinogen. The transcapillary flux 
was 171 mg/kg/day in the young and 8l mg/kg/day in the older rabbits. 
The fibrinogen catabolic flux averaged 56.5 and 39 mg/kg/day in the 
young and older animals respectively. The interstitial to plasma 
fibrinogen ratio was 0.20 and 0.36 in the older and young rabbits 
respectively. The total plasma fibrinogen in 7 older rabbits 
averaged 106 mg/kg and the total interstitial fibrinogen 22 mg/kg
compared with respective values of 118 and k2 mg/kg in the young 
rabbit. Both, the transcapillary and catabolic fluxes behave as 
though governed by either an unsaturated or a volumetric clearance 
system.
This abstract of about 250 words is approved as to form and content. 
I recommend its publication.
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INTRODUCTION
Properties of the Coagulation Reactants
The formation of fibrin in blood or plasma follows the action of 
thrombin on fibrinogen. Thrombin, in turn, is the product of a series 
of reactions not yet well understood. In what follows, the properties 
of fibrinogen, thrombin, and fibrin will be listed. This will be 
followed by a brief description of the nature of the reaction between 
thrombin and fibrinogen, the conditions which influence the reaction, 
and the physiological significance of their product, fibrin.
Fibrinogen
Fibrinogen has been defined as the plasma protein which forms 
fibrin when acted upon by thrombin. It has been found under normal 
conditions in the blood and in lymph, and in the spinal fluids 
and effusions or exudates in pathological conditions.
Fibrinogen makes up 3 to 6 per cent of the plasma proteins and 
is readily precipitated with neutral salts. It is heat labile; 
its isoelectric point occurs at pH 5-5 (l)j and its molecular 
weight has been estimated to be near 350,000 ( 2). The shape of the 
molecule has been suggested to be intermediate between an ellipsoid 
and nodular rod (3). Electron photomicrographs show that the
molecule is a rod kJ3 A° long with two terminal modules of 65 A° in
diameter and a smaller centrally located nodule ( ^ ) •
The aminoacid composition of fibrinogen has been tabulated (5)
2and consists of 19 amino acids with terminal tyrosine and glutamic 
amino acids (6).
Thrombin
Thrombin is the natural coagulant of fibrinogen and manifests 
its activity only after activation of the clotting mechanism.
Thrcmbin can be obtained experimentally from purified prothrombin 
in two ways. It can either be obtained by activating prothrombin 
with tissue (brain or lung) extracts in the presence of calcium ions 
and factor V to yield "biothrombin" (j), or by activation of 
prothrombin by high concentrations of citrate to yield "citrate 
thrombin" (3). The molecular weight of "biothrombin" has been 
estimated as 62,000 (3) and that of citrate thrombin as 31,000 (3). 
Thrombin preparations of 15,000 to 20,000 molecular weight without 
loss of clotting activity have also been described (8).
The functional activity of thrombin is that of a highly specific 
proteolytic enzyme (7). Its activity is destroyed by strong acids 
and alkalis and by heating to 60°C. In plasma, the activity of 
thrombin is neutralized by antithrombins (9). Antithrombins have 
been shown to neutralize enormous amounts of thrombin (10).
The most familiar substrate of thrombin is fibrinogen, though 
thrombin has been shown to hydrolyze the synthetic esters of p-toluene 
sulfonyl-L-arginine (TAME) (ll)j the lysine ethyl and methyl esters; 
and lysyl-alanine bond in the oxidized B chain in insulin (8)l Dis­
agreement as to significance of the esterase activity of thrombin 
exists, but some feel clotting and esterase activity are inseparable 
(12) while others consider that clotting activity functions to release
3subunits from prothrombin which posses esterase activity (13).
The Mature of the Thrombin-Flbrinogen Reaction
The way in which the enzymatic action of thrombin leads to the 
formation of fibrin has now largely been clarified. The first 
effect of thrombin on fibrinogen is that of partial proteolysis 
with the rupture of arginyl-glycyl bonds in the fibrinogen 
molecule with the loss of negative charges due to the removal of 
peptides (l4). The loss of negative charges from the fibrinogen 
molecules results in the formation of monomers which are led to 
polymerize by the electrostatic attraction which has replaced the 
mutual repulsion which existed (15). This polymerization process 
is thought to take place in stages which depend on the pH and ionic 
strength of the media. Hie first stage in polymerization is the 
end to end alignment of the monomers to form an intermediate polymer 
(4). At the later stage, the intermediate polymers undergo 
side to side aggregation to form the coarse fibrin strand seen 
with the light microscope. If the reaction takes place in 
the plasma, the fibrin strands undergo further changes. It 
has been shown that plasma contains a "fibrin stabilizing factor" 
which renders fibrin insoluble in urea (16). Evidence has been 
cited that this factor forms S-S bonds (17). The knowledge of the 
sequence of events leading to the fomation of fibrin from 
fibrinogen has been the result of the work of Mihalyi (l9)>
Lorand (15) (l8), Bettelheim (19)) Laki (20), Bailey (2l),
Scheraga (8), Hall and Slayter (*0, and their co-workers.
kDiagrammatic ally, the reactions may he listed as follows:
1) proteolysis
2) polymerization
3) clotting
k) stabilization
T
■> fn,
mfn------> fibrin (soluble),
fibrin (soluble) — > fibrin (insoluble)
where F is fibrinogen, T is thrombin, f is fibrin monomer, m and n 
are variable integers and FSF is the fibrin stabilizing factor.
Conditions Which Influence the Fibrinogen -Thrombin Reaction
The thrombin-fibrinogen reaction has been studied using both 
purified fibrinogen solutions and blood plasma.
Using purified fibrinogen solutions, many factors, both real 
or environmental, have been shown to alter the speed of the reaction. 
Most purified solutions contain a cold insoluble material (22) 
which has been termed "profibrin” (23)- This profibrin reacts more 
rapidly with thrcmbin than with the dissolved fibrinogen (2b).
Thus, the presence of this material in fibrinogen solutions may 
influence the overall rate of reaction. Other factors known to 
influence the speed of the reaction have been discovered. Owren, 
for instance, found that the concentrations of fibrinogen and 
thrcmbin were important and suggested that the optimum fibrinogen 
concentration was 0.1 per cent when dilute solutions of thrombin 
were used (2b). The concentration of salt in the media may also 
delay for formation of fibrin (25). Alterations of pH beyond the 
limit of 6.5 to 7-5 also have marked effects on the formation of 
fibrinogen and thrombin, and the concentration of calcium are 
other factors which affect the reaction.
5Using plasma, on "the other hand, many of the environmental 
factors are automatically controlled. The salt concentration and 
pH, for example, are fairly constant for most plasmas. Though these 
factors are well controlled in plasma, plasma may contain substances 
vhich will act on the newly formed or added thrombin and alter the 
rate of the reaction. Very little is known about the thrombin- 
fibrinogen reaction in plasma.
Pro-perties of Fibrin and Its Physiological Significance
The physical properties of fibrin are well known. Clots formed 
by normal blood are able to withstand tensions of about 50 grams 
per square centimeter (26). Fresh fibrin has strongly adhesive 
properties and adheres to various surfaces such as glass, metals, 
and body tissues (27). Electron photomicrographs of fibrin show 
that fibrin is cross striated with a periodicity of about 230 A 
with fine intermediate bands (4). Hall and Slayter (4) suggest 
that the darker bands correspond to the terminal nodules and the 
lighter ones to the central nodules of the fibrinogen molecule.
If this interpretation is correct, the fibrinogen molecules have 
been shortened from 475 A° to 230 A° by the action of thrombin 
or during the polymerization process. As indicated above, fibrin 
formed from purified solutions is soluble in strong urea solution 
but that derived from plasma is insoluble in this solvent (l6).
The main physiological function assigned to fibrin formation 
in vivo is that of hemostasis. Blood coagulation in addition to 
platelet agglutination, contraction of damaged vessels, and 
adhesion of the walls of minute vessels forms an integral part of
6the hemostatic mechanism in mammals.
Another physiological function for fibrin has been postulated, 
though insufficient evidence in support of this view exists. It has 
been postulated that fibrin is continually formed within the blood 
vessels and that a fibrin layer lines the lumen of the vessels (28). 
Copley considers the fibrin to be essential for the integrity of
blood vessels and that it aids in facilitating the flow of blood
through the capillaries by reducing the apparent viscosity of 
blood (29). This idea of simultaneous clotting and fibrinolysis
was originated by Nolf in 1908 and he regarded this process as a
normal metabolic process (30). In support of this view of 
continuous formation of fibrin with deposition on the endothelial 
wall-can be cited from the rapid turnover of clotting factors 
(31) (32) (33). If this view is true, then, the relative rates 
of fibrin formation and removal play an important part in the 
maintenance of the vascular patency and endothelial integrity 
and fibrinolysis then becomes an important antithrombotic 
activity. The rate of fibrin formation, therefore, must be 
delicately counterbalanced by the fibrinolytic activity to ensure 
no net depletion or accumulation of fibrin on the wall of the 
vessels. An excellent review on fibrinolysis has been published 
by Von Kaulla (3*0 •
•£* Vivo Studies of Fibrinogen
Knowledge about fibrinogen has come largely from in vitro 
studies, for instance, of the changes in the rate of fibrin formation 
in reconstituted synthetic systems and from studies of abnormal
7coagulation in disease. Awareness that blood removed from the
circulation may not hehave the same as circulating blood in the
animal, has stimulated investigations of the coagulation system
in the intact animal. With the advent of radioactive tracers of
isotopes, one approach has been to label fibrinogen with the
radioactive isotope and study its rate of disappearance from
the animal's plasma. So far, however, only knowledge of the
"turnover rate" and the "half-life" of fibrinogen in various
animals has been derived from these studies (35) (36) (37) (38) (39).
Among the first to study the fibrinogen system in vivo were
Madden and Gould (36). These investigators fed S3^ -labeled amino
acids to dogs and humans and then followed the rate of disappearance
of labeled fibrinogen from the circulating plasma by isolating
fibrin and determining the number of counts of radioactivity in
a given mass of fibrin. They found the half-life in the dog was
k.2 days and in the human 5*6 days. Later, Cohen et al. (39)
ill-followed disappearance of C biosynthetically labeled fibrinogen
131and compared it with that of in vitro labeled I -fibrinogen
131in rabbits. They listed the mean half-lives of I -fibrinogen
as 66 hours and C"^ -fibrinogen as 68 hours in their rabbits.
Other studies using C1*4, S^, and I131 tracer-labeled fibrinogen
have been carried out by Dovey et al. (40), Lewis and Ferguson (36),
Christensen et al. (37), Gerdes and Maurer (45), and Blomback
14et al. (4l). In most instances, the half-life of the C and 
S^ labeled fibrinogen is longer than that of the I131-fibrinogen.
In all of these studies, the rate of disappearance of the labeled 
fibrinogen was obtained from specific activity measurements.
'H
aa
mo
a
8Evidence that S35 and C^-labeled amino acids liberated by the 
35 1^catabolism or S and C tracer-labeled proteins are reutilized
by the animal for tissue protein synthesis was presented by
Walters et al. (te) and Fleischer et al. (^ 3)« These investigators,
35 iIj.using doubly-labeled S and C homologous albumins and globulins,
shoved that the ratio of s^/clk in the tissue was 0.9 to h.6
times greater than the S^/c1  ^ratio of the albumin in the plasma.
For doubly-labeled globulins, the tissue S^/c1^  ratio was from
1.1 to 6.7 times greater than the doubly-labeled plasma globulins.
In Keratin, for instance, which contains large amounts of sulfur,
35 1 *^the highest S /C ratios were found. Theoretically, the tissue
to plasma ratio should be equal to 1.0 if S was not utilized
14more preferentially than the C -labeled amino acids which may 
undergo other metabolic fates than protein synthesis. Using 
doubly-labeled S3^  and I131 -albumin, these investigators found
9 days after the intravenous injection of the protein that the 
tissue to plasma S3 /^l131 ratio was 3 to l4 in the rabbit and 
50 to 100 times in the rat. They attributed this difference to 
the more rapid metabolism in the smaller animal, and to reutilization 
of the S3^ -labeled amino acid for tissue protein synthesis.
These experiments point out, further, that the I^ 3^ -label is 
not utilized for tissue protein synthesis, thus, suggest a tracer 
to circumvent the problem of reutilization. Since the breakdown
131products of I13 -labeled proteins consist largely of inorganic I 
iodide, however, some investigators suspected that this represented 
a deiodination process. Walters et al. (42) showed, however, that 
the ratios of I^/s35 and I131/ ^  of doubly-labeled proteins in
9the plasma decreased only slightly. This indicated that the
disappearance of the I131-labeled protein was not by simple
deiodination and that it reflected the true metabolic rate
of the protein. This slight decrease in the ratio, I131/^, in
the doubly-labeled plasma proteins can be attributed to slight
illreutilization of the C -labeled amino acids liberated after 
catabolism of the protein. McFarlane, also, has found good 
correlation in the decline of the specific activity of I131/ ^  
doubly-labeled albumin and fibrinogen (hh) (46).
Much of the work done using I131-fibrinogen does not list 
the iodine atom to fibrinogen molecule ratio of iodine substitution. 
McFarlane (hh) has shown that iodination of albumin with an iodine 
to protein ratio greater than 3*0 leads to altered biological 
behavior of the I131-albumin. Over-iodination of fibrinogen may 
also lead to altered biological behavior of the I131-fibrinogen.
Purpose of the Investigation and Requirements for a Comprehensive 
Study.
The purpose of this investigation is to establish a method 
for studying and characterizing fibrinogen in the living animal 
under normal conditions. This will provide a basis of comparison 
for later studies of fibrinogen metabolism in disease states 
and other abnoimal conditions, and, it is hoped, will allow intelligent 
interpretation of such studies. Before a meaningful study of the 
metabolism and distribution of fibrinogen can be carried out in 
the living arHma.1 methods are required for purifying and labeling 
fibrinogen, for quantitating plasma fibrinogen, and for
10
establishing the permissible levels of iodine substitution 
in fibrinogen. For interpreting the results obtained, on the 
other hand, a schema of the fibrinogen system which can be described 
mathematically must be developed and evaluated using tracer labeled 
fibrinogen. If the tracer model describes accurately the data, 
the differential equations describing the system will be solved 
and their solutions used to carry out kinetic analysis of the 
data. In this manner, it is hoped that the dynamics of the 
fibrinogen system in the living animal can be characterized more 
completely.
CHAPTER I
Purification of Fibrinogen
Fibrinogen used for labeling with I131-iodide for in vivo 
metabolic studies must be exceptionally pure and as nearly in 
the native state as possible.
Fibrinogen was first identified by virtue of its insolubility 
in concentrated salt solutions (49) and its instability to heat (48). 
Hammarsten in 1879 separated and purified this protein by simple 
salting out with half-saturated sodium chloride (22). For many 
years this was the method used (49) (50) (51) (52); other salts 
such as ammonium sulfate (53)> potassium phosphate (54), and, 
more recently, the sodium salt of heparin (55) have also been used 
to purify fibrinogen. Other procedures used employed isoelectric (56), 
ethanol (57)> and ether (58) precipitation and DEAE cellulose 
column chromotography (59)*
The initial separation of fibrinogen from plasma using these 
methods is accomplished readily. Further purification of fibrinogen 
is made difficult by the ever-present danger of clotting, by the 
lability of the fibrinogen, and by the presence in the original 
crude precipitate of small quantities of material which is less 
soluble than fibrinogen. The danger of clotting, however, may be 
reduced somewhat by collecting the blood free of tissue fluids (60) 
and using excess anticoagulant, preferably sodium citrate. Further
12
procedures for the purification of fibrinogen should involve as 
few steps and require as little time as possible, and should avoid 
conditions and repeated use of reagents known to cause denaturation. 
The problem of material which is less soluble than fibrinogen can 
be dealt with during the later stages of purification when a 
reasonably pure fibrinogen preparation has been obtained.
The above considerations ruled out methods of purifying 
fibrinogen involving the use of acid pH, large surface areas, and 
organic solvents, since proteins have been known to be denatured 
by these conditions. Attention was, therefore, focused on methods 
employing serial precipitation plasma fibrinogen with neutral salts. 
After several attempts to obtain fibrinogen of high clottability 
by precipitation with sodium chloride and potassium phosphate had 
failed, these were abandoned in favor of ammonium sulfate 
precipitation. Applying serial precipitation to the fibrinogen 
with this salt, preparations containing 90 per cent clottable 
protein were obtained. The recovery of the plasma fibrinogen 
was low, however, and the procedure involves excessive manipulation 
(7 or 8 reprecipitations) of the protein. Morrison et al. (6l) 
showed that the electrophoretic components present in Cohn Fraction I 
consisted of 7$ albumin, 8$ alpha-globulin, 15$ beta-globulin,
9$ gamma-globulin and 60# fibrinogen. Thus, it seemed reasonable 
to assume that these proteins would also be present in the crude 
fibrinogen-salt precipitate. Since all the proteins listed above, 
with the exception of fibrinogen, are soluble in one-quarter 
saturated ammonium sulfate, it was decided to extract them from 
the precipitate with this concentration of ammonium sulfate.
13
In this manner, fibrinogen preparations of good yield and 
containing 90 to 93 per cent clottable protein were obtained with 
less manipulation than serial precipitation. Further reprecipitations 
and extractions with this concentration of salt failed to improve 
the clottability of the fibrinogen preparations. Thus, it 
appeared as if a non-clottable material was present which was less 
soluble than fibrinogen in this concentration of ammonium sulfate. 
Morrison (62) in 19^ 7, and Edsall (63) in 1948 noted that a cold 
insoluble material was present in the Cohn Fraction I and that it 
precipitated on cooling and dissolved on warming and behaved unlike 
fibrinogen in many respects. In view of this observation, fibrinogen 
preparations were placed in the cold at 4®C for 10 hours and the 
cold insoluble material which formed was centrifuged off at 0°C at 
4,500 rpm for 20 minutes. This treatment increased the clottability 
of the fibrinogen preparations by as much as 6 per cent.
Method for Purifying Fibrinogen
The procedure developed for separating and purifying fibrinogen 
from platelet-free rabbit plasma was as follows: 30 to 40 ml of
rabbit blood were collected by cardiac puncture from a donor 
rabbit, and immediately mixed with an equal volume of 2.5 per cent 
sodium citrate in polyethylene centrifuge tubes. The citrated blood 
was then spun at 2,000 rpm for 3® minutes and the platelet-free 
plasma was collected and made l/4 saturated with ammonium sulfate 
by mixing three parts of plasma with one part of 100 per cent 
saturated (at 37°C) ammonium sulfate. At this concentration of 
salt, the fibrinogen precipitate was evident. After allowing the
14
precipitate to form for 30 minutes at room temperature (25-29°C), 
it was collected lay centrifugation at 2,000 rpm for 10 minutes.
The supernatant was discarded by decanting and the test tubes were 
inverted and allowed to drain over a clean paper tissue for 5 to
10 minutes. The occluded or adsorbed non-clottable proteins were 
extracted by suspending the precipitate in 10 ml of l/4 saturated 
ammonium sulfate for 20 minutes at room temperature, (the precipitate 
was suspended by dispersing it with a clean, fire-polished, 
siliconized glass rod). Following two such extractions, the 
precipitate was dissolved in 15 ml of 0.005 M sodium citrate and 
reprecipitated by adding 5*0 ml of 100 per cent saturated ammonium 
sulfate to the solution. This time, the precipitate was allowed 
to form for 10 minutes instead of 30 minutes. After collection 
and further extractions of the precipitate with l/4 saturated 
ammonium sulfate, the fibrinogen was dissolved in 2 to 3 ml of 
0.005 M sodium citrate. The concentration of the fibrinogen 
solution at this point was near 12 mg/ml and the clottability was 
usually between 90 and 93 per cent. (If the clottability was 
below 90 per cent, the solution was diluted to 15 ml with 0.005 M 
sodium citrate and reprecipitated once more with 4.0 ml of 100 
per cent saturated ammonium sulfate*). The preparation was then 
placed in the cold at 4°C for at least 3 but not more than 12 hours.
* The clottability of fibrinogen preparations at this stage 
is not improved by further precipitations with 1/4 saturated 
ammonium sulfate. Therefore, it sometimes becones essential 
to lower the concentration of this salt in order p
the clottability of fibrinogen preparation.
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The cold insoluble material was removed by centrifuging at 0°C 
and 4,500 rpm for 25 minutes. This yielded a preparation that 
was 94 to 98 per cent clottable with thrombin.
Criteria for Purity of the Fibrinogen Preparations
As implied above, the ratio of clottable to total protein was 
taken as a measure of purity. The basis for this assumption is 
that fibrinogen is the only known plasma protein which forms fibrin 
when treated with thrombin. Also, it has been shown that 95 to 
97 per cent clottable fibrinogen is homogeneous in the ultra­
centrifuge (64) and it behaves as a homogeneous protein in starch 
gel and moving boundary electrophoresis. See Figures 1 and 2.
The percentage clottability was determined by two independent 
methods of measuring the clottable and non-clottable protein and 
excellent agreement was obtained between the two. Hie methods for 
measuring the percentage clottability will be described later.
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Figure 1. Electrophoretic patterns of fibrinogen which was 
95# clottable (B and D) and blood serum (c) using starch gel medium 
in pH 8.5 borate buffer. (E = 180 volts, i = 5-6 ma, time = 19 hours)
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Figure 2. Photograph of an electrophoretic patterns of 
l<f> fibrinogen (9^ clottable) in pH 8-5 veronal buffer obtained 
by tiselius moving boundary method, (ionic strength = 0.1-0.2, 
E = 155 volts, i = 8 ma, time “ 3 hours)
CHAPTER II
Iodination of Fibrinogen
Various radioactive labels have been used to label proteins.
l4 35Proteins have been labeled in vivo by feeding C or S -labeled 
amino acids or protein hydrolyzates to experimental animals and 
humans (35) (36). In vitro labeling of proteins has been 
accomplished mainly by using I1^ 1-iodine under carefully controlled 
conditions.
The procedure involved when C1^  or S^-labeled proteins are 
used in metabolic studies is to remove the blood from an animal 
fed radioactive labeled amino acids or protein hydrolyzates after 
sufficient radioactivity is present in the plasma proteins (65).
The desired protein is then fractionated and the purified labeled 
material is then injected into a recipient experimental animal. Such 
physiological labeling of proteins is highly desirable; however, 
it does suffer from the following distinct disadvantages: l) the
possibility of reutilization of the labeled amino acid breakdown 
products exists; 2) the labeling procedure as well as the counting 
procedure are time consuming and require expensive radiation 
detection apparatus; 3) the specific activity of the protein 
usually low; consequently, large amounts of the desired protein 
have to be infused (65); and, k) acme plasma proteins appear to he 
synthesized fn. amino acid pools of higher specific activity (66),
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and thus contain amino acids of a higher specific activity.
Separation of a protein of low specific activity from one of 
higher specific activity may lead to denaturation and uncertainty 
about the satisfactoriness of the labeled material.
In vitro labeling of proteins has the following advantages 
over in vivo labeled proteins: l) the methods are less time consuming
and the protein is labeled with relative ease; 2) the desired specific 
activity can be introduced so that only traces of the labeled protein 
need be injected; 3) I -radioactivity measurement requires less 
expensive and complicated apparatus and accurate measurement is not 
difficulty and, 4) the I131-protein breakdown products are 
quantitatively excreted (67).
Many methods of iodination of proteins have been developed.
All of them utilize iodine in the plus (l+) oxidation state as the 
active species. The active iodine has either been preformed as 
1  ^or prepared by oxidation of the iodide with nitrous acid (68), 
iodate (69), or hydrogen peroxide (70) just before use. The 
iodination of proteins is usually performed by mixing the active 
species of iodine with the protein buffered at a pH of 8 to 10.
At this pH, the hydroxyl group of the tyrosyl moiety present in the 
protein dissociates or ionizes creating an electron density ortho to 
the hydroxyl group and the electrophilic iodine (I ) substitutes 
rapidly (7l)*
The use of oxidizing agents to oxidize iodide to iodine presents 
the danger of introducing traces of oxidizing agents which may 
attack the protein by oxidizing SH groups.
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Recently, however, a method which offers the theoretical 
labeling efficiency of 100 per cent incorporation of the label into 
proteins was proposed by McFarlane (72). The method employs iodine 
monochloride, ICI, as carrier. This reagent is prepared in the ab­
sence of oxidizing or reducing agents in an excess of HC1. The radio­
active iodine monochloride is made by exchange between the iodine 
monochloride and the radioactive I131-iodide.
Preparation of Iodine Monochloride (72)
The iodine monochloride is prepared according to the following 
reaction discovered by Andrews in 1903 ( 73)*
6HC1 + 2 Nal + NaI03 _____________ ^ 31C1 + 3NaCl + 3H20
In an excess of concentrated HC1 (sp. gr. 1.18) the reaction forms 
mostly ICI instead of 1^  as is the case when dilute acid is used (73)«
To prepare iodine monochloride, take 4.97 ml of 0.1 M NalO^  and 
mix well with 10 ml of 12 N HC1 (sp. gr. 1.18) and add dropwise
1.00 ml of 1.00 M Nal with constant stirring. Transfer the yellow 
mixture to a glass stoppered graduate cylinder or volumetric flask 
containing 5.0 ml of chloroform, make to a 50 ml volume with distilled 
water and shake vigorously. Allow the chloroform layer to settle
to the bottom of the cylinder. If the chloroform layer is pink,
repeat the treatment with chloroform until it remains colorless.
To remove the dispersed droplets of chloroform from the iodine 
monochloride solution, bubble air through the solution for at least 
an hour. The solution is 0.033 M in ICI and 3 N in HC1 at the final 
dilution. This solution is exceptionally stable and reacts with 
proteins in the hypoiodite form only.
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The hypoiodite ion is produced "by raising the pH of the IC1 to 
pH 8.5 or higher. Above the pH of 10 the IC1 solution is unstable.
131Removal of Hydrogen Peroxide and Sulfite from Nal
The removal of peroxide and sulfite is in accordance with the
following reaction:
1) so‘“ + h2o2 ------->  so;- + h2o
. 100°C ^
2) S03 + 1/2 02 pH 7.6 S°h
The presence of peroxides in aqueous solutions of radioactive material 
is expected as a result of ionizing radiation on water. However, 
Helmkamp was first to produce evidence that peroxides were present 
in sodium I131-iodide obtained from Oalcridge (7*). He found that 
an I131-iodide solution of 37-5 millicuries per militer contained 
1 x 10~k m mols of H ^  eight days after it had been produced. In 
view of this finding, sulfite was added routinely to shipments of 
Nal131 upon arrival. Usual^ 0.10 ml of 0.05 M N a ^  was added.
' Before using the radioactive material to label proteins the 
excess sulfite should be removed. The sulfite was removed by 
reaction 2. It was found that bubbling air through the radioactive 
iodide at boiling water temperature and neutral pH removed up to 10 mg 
of sulfite in 20 minutes with little or no loss of radioa 
The aparatus used to remove the sulfite is shown in Figure 3-
Preparation of I13IC1
ttis solution uas prepared hy si^r mining the calculated^*
of 101 vith the desired amount of peroxide and sulfite-free Ha! .
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Figure 3. Apparatus for removing sulfite from radioactive
I 3 -iodide solutions.
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The solution should he allowed to equilibrate for at least 30 minutes 
before using it to label proteins.
Iodination of Fibrinogen with ICI
A small volume of sodium iodide- I131 of high specific activity 
and free of peroxides and sulfite was used. The ICI and the radio­
active iodide were mixed and cooled to 0°C in an ice bath. The 
amount of ICI added to the radioactive iodide was calculated to 
obtain the desired ratio of iodine atoms to protein molecules.
Thus, if E is the efficiency of the iodination and iodine atoms 
are added to m2 protein molecules, the iodine labeled protein will 
contain an average of E m1/m2 iodine atoms per molecule. The 
efficiency of iodination by the method described below when 
mj^ tig was 30 "to 50 per cent. Hence, when 0.01 ml of 0.0033M ICI 
is added to 11 mg of fibrinogen (M.W 350,000) the number of iodine 
atoms is approximately equal to the number of fibrinogen molecules, 
flrnd the final iodinated protein will contain an average of less 
than 0.5 atoms of iodine per molecule of fibrinogen.
To label fibrinogen of 93 "to 98 per cent clottability, take
11 to 15 mg of fibrinogen in a volume of from 0.5 to 1.0 ml, cool 
the solution to 0°C in an ice bath, and make to pH 9*0 with 0.2 ml 
of 1.0 M glycine buffer (v/v 8 parts M glycine in 1.5 per cent NaCl 
to 2 parts N NaOH). At the same time, the iodine monochloride-I1 
mixture is brought to pH 8.5 with 0.2 ml of 1.0 M glycine buffer 
(v/v 9 parts M glycine to 1 part N NaOH). The protein and I1 Cl 
are then jet mixed hy forcible injection of the r^Cl through a 
narrow glass nozzle or Pasteur pipette into the protein solution.
2b
The substitution of iodine into the protein is instantaneous.
The volume of the solution is now immediately brought to 6.0 ml 
with 0.005 M sodium citrate and the fibrinogen is precipitated by 
adding 2.0 ml of saturated ammonium sulfate. The unbound r^l 
wliich remains in the supernatant after centrifugation is removed as 
completely as possible. The precipitate is then suspended in l/k 
saturated ammonium sulfate and centrifuged down. This step is 
repeated till less than 1 per cent of the total activity in the 
solution is not protein bound. The unbound activity is that 
activity which is not precipitable with 10 per cent trichloroacetic 
acid.
Determination of Clottability
Percentage clottability was used as a measure of the purity of 
the fibrinogen preparation. It was measured either from the change 
in soluble X^^-fibrinogen content or the change in soluble protein 
content after the addition of thrombin solution.
Two equal volumes of a fibrinogen or T^-fibrinogen preparation 
were diluted to k.O ml with 0.005 M citrate. In one, the radio­
activity (cpm/ml) of the solution was measured and to the other 0.2 ml 
of thrombin (20 NIH units/ml in 50 per cent glycerol) was added.
After some five minutes, the opaque fibrin clot was collected on a 
glass rod as described below. The solution was then allowed to sit 
for one hour longer, in order to allow the thrombin-fibrinogen 
reaction to proceed to completion, and any additional fibrin which 
formed during this time was also collected. The radioactivity 
(cpm/ml) of the clot liquor was then measured. The per cent
25
clottability (#c) vas then given by:
100 (H, - R2)
R1
where R1 = radioactivity (cpm/ml) before the addition
of thrombin
^2 = radioac-fcivity (cpm/ml) after the addition 
of thrombin and removal of the fibrin clot.
When the protein method was used, equal volumes of the
fibrinogen preparation or labeled I^^-fibrinogen were diluted as
described above with 0.005M citrate. Then the optical density,
e1, of the fibrinogen solution was measured at 280 mu wave length
in one cm optical path length, quartz, cuvets. To the other test
tube and a blank (4.0 ml of citrate) was added 0.2 ml of bovine
thrombin. The fibrin was collected as described above a-nfl the
optical density, e^ , of the clot liquor was measured against the
citrate blank. The #C was then calculated as follows:
(el - e2>
el
Excellent agreement between the clottability measurements by both 
methods was found. See Table I.
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CHAPTER III
Isotope Dilution Method for Measuring Plasma Fibrinogen
Fo* studies of the metabolism and distribution of fibrinogen 
in animals, an accurate method of quantitating the plasma fibrinogen 
concentration was required. The current methods, the better of which 
are listed in Table II do not give accurate results. These methods 
depend on separating the fibrinogen from the plasma by heat 
coagulation, salt precipitation or fibrin formation and then 
determining the quantity of the separated protein by weight, or 
chemical or physical measurements. To determine the accuracy of 
these methods, measurements of the completeness of fibrinogen 
separation from plasma and of the extent of occlusion of other plasma 
proteins in the separated fibrinogen were made, using the three most 
often cited principles for separating fibrinogen.
fvw.eteness of Fibrinogen Separation frcm Plasma b£ Heat Coagulation,
Thrombin, and Salt Precipitation
This was measured by adding a small amount of I131-fibnnog<m 
which ms 96 per cent clottable, before and after labeling with I , 
to a number of citrated rabbit plasma samples. The fibrinogen vas 
then separated from the plasma samples by standard methods and the
amount of radioactivity remaining in the plamna after removal of
• *4- +« r>r* fibrin was measured. T&is radio- the fibrinogen precipitate or fibr
+ then corrected for the percentage, #C, ofactivity measurement was tnen
28
TABLE II
METHODS FOR MEASURING FIBRINOGEN
Method 
Isolating Fibrinogen
Method 
of Quantitation Investigator
l) Heat Coagulation dry weight Fredericq (78)
Nitrogen
content
Gram (79), Whipple (75), 
Lewis and Ferguson (35)
Turbidimetry Stirland (76)
2) Salt Precipitation dry weight Rehye (77) and 
Lewinski (80)
Nitrogen
content
Howe (8l), Florkin (82), 
Campbell and Hanna (83)
Turbidimetry Podmore (84)
3) Thrombin - induced 
Fibrin Formation
dry weight Szecsenyi-Nagy (85) 
Foster and Whipple (86)
Nitrogen
content
Cullen and Van Slyke (87 
Howe (88) and Jones and 
Smith (89)
Tyrosine
content
Wu (90), Wu and Ling 
(9l), and Ratnoff (92)
Turbidimetry Losner et al. (92) and 
KLinke and Elias (94)
Clotting time Adamis (95)
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the fibrinogen preparation that was not clottable.
Then, $C x cpm separated from the plasma
cpm of I^ 31-fibrinogen in the plasma 
gives the percentage removal of fibrinogen from the plasma. After 
adding the I'L31-fibrinogen to each plasma sample, the sample was 
then divided into three portions. The fibrinogen in the first 
portion was heat coagulated as described by Lewis and Ferguson (35), 
that in the second was treated with bovine thrombin as described by 
Ratnoff (92), and the fibrinogen in the third portion was precipitated 
with one-quarter saturated ammonium sulfate, after the plasma had 
been diluted ten-fold with 0.005 M sodium citrate. Measurements 
were made in triplicate. Table III records the results and shows 
that an average of 19*5, 11.0, and 5  ^per cent of the total fibrinogen 
was not separated by heat, thrombin and ammonium sulfate treatment 
respectively; or with an average fibrinogen level of 300 mg per 100 ml 
of plasma, 59, 33, and 150 mg per 100 ml were not separated.
Occlusion of Proteins Other than Fibrinogen in Separated Fibrinogen 
or Fibrin
131The proteins in rabbit blood serum were labeled with I 
iodide and small amounts of the labeled serum were added to a series 
of citrated rabbit plasmas. The samples were again divided into three 
portions and the fibrinogen was separated by heat coagulation and 
fibrin formation as described above. (Studies on ammonium sulfate 
precipitation of fibrinogen were not done because of the large 
errors noted above.) The coagulum and fibrin were then separated 
by centrifugation, washed three times with 0.9 per cent NaCl solution
30
TABLE III
PERCENT SEPARATION OF FIBRINOGEN FROM PLASMA BY HEAT, BY THROMBIN 
AND BY ONE-QUARTER SATURATED AMMONIUM SULFATE
Sample No. Heat
Coagulation
Thrombin Ammonium
Sulfate
1 79.4# 88.7# 75#
78.8 89.9 4o
78.8 90.2 52
8O.3 87.3 42
80.2 88.3 51
2 79.0 89.4 35
82.4 89.I 39
3 82.8 89.3 33
83.O 88.6 50
Mean 80.5 89.O 46.3
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and counted in well scintillation counter. The radioactivity found 
in the separated fibrin or precipitate was taken as an approximate 
measure of occluded protein. Table IV shows the results of these 
experiments when the occluded protein was calculated from:
cpm of I131 found in precipitate or fibrin x S —— . _
cpm of I per ml of plasma 
where S is the average serum protein concentration per ml and was 
taken as 70 mg/ml. It is seen that an average of I.36 mg of protein 
was occluded in the heat coagulum from 1.0 ml of plasma and 3*66 mg 
in the fibrin clot formed from 1.0 ml of plasma, or roughly speaking, 
the fibrinogen concentration would be 1.45 and 2.22 times its time 
value by the two methods respectively.
It is thus clear that incomplete separation of fibrinogen, on 
the one hand, and occlusion of other plasma proteins on the other, 
cause serious errors in measurements of plasma fibrinogen concentration. 
The errors are in opposite directions and will only by chance cancel 
each other out.
Isotope Dilution Method
A possible way of circumventing the difficulties of incomplete 
separation and protein occlusion in the determination of fibrinogen 
is to use the isotope dilution principle. In accordance with this 
principle, if a small quantity, r-j., of pure radioisotope in a volume 
Vj is mixed thoroughly with an unknown quantity, Q, of non-radio- 
isotope contained in a given volume, Vg, one can readily detennxne 
the quantity of Q provided the substance can be isolated in pure 
fom. For if the radioisotope is evenly distributed and behaves
BOULDER, 
COLORABO
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TABLE IV
PERCENT OF OTHER SERUM PROTEINS* OCCLUDED IN FIBRIN CLOTS
AND HEAT PRECIPITATES
Sample No. Heat Thrombin
Coagulation Treatment
1 3-5$ 6.1$
1.6 3-8
1.7 3.6
2 1.5 5.0
1.6 11.3
2.4 4.4
3 1.8 3-3
1.8 4.9
1.6 4.7
Mean 1-9 5-2
Calculated weight of occluded
non-fibrinogen protein per
366 mg100 ml of plasma: 136 mg
*Expressed as per cent of total non-fibrinogen proteins 
present. The total serum protein was taken as 70 mg/ml.
BOULDER 
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identically as the rest of the non-radioactive atoms, the material 
need not he isolated completely, because any fraction of the material 
isolated will contain the same ratio of radioactive to non-radio- 
active atoms. Thus, if one measures the radioactivity per unit 
volume, Nj (cpm/ml), of the mixture and the radioactivity per
unit mass, N2 of the isolated substance (cpm/mg), the quantity,
Q (mg/ml), can be calculated from the following equation:
Q = ( N ^  - rI/V]; + Vs) (Vj + Vs)/Vg
where Q = mg/ml of substance being measured 
Nj= cpm/ml of solution
N^ = cpm/mg of substance isolated (specific activity)
r^ = mg of radioisotope added
Vj= volume of the radioactive solution added (ml)
V = volume of the solution containing the non-radio-
3 active substance (ml)
The above equation contains corrections for dilution from the addition
of Vj, and for the addition of the radioactive material v^ . This
principle cannot be applied to the quantitation of proteins readily,
since only few proteins can be isolated in pure form. However,
fibrinogen can be converted to fibriii and fibrin can be isolated
reasonably free from other plasma proteins. Therefore, if a small
quantity, f^  of r^-fibrinogen containing the optimum amount of
iodine atoms per molecule of fibrinogen, is thoroughly mixed with
the unlabeled fibrinogen in a volume of plasma containing F
mg/ml of fibrinogen, the quantity F can be calculated as described
above. On the one hand, the quantity (cpm/ml) in the plasma
is measured directly, and on the other, the quantity (cpm/mg)
of fibrinogen can be determined from fibrin. That is:
F = C (Nj/Ng - fI/V]. + Vp) (Vj + Vp)/Vp - mg/ml of 
plasma fibrinogen
where C = the fractional clottability of the I131 -fibrinogen
cpm/ml of plasma
N2= cpm/mg of fibrin
mg of I131-fibrinogen added to the plasma
the volume of i131 -fibrinogen solution added
V » volume of plasma P
This formula can be used to calculate the quantity of fibrinogen 
but for in vitro measurements the parameters f a n d  have to 
be measured accurately. For in vivo studies, however, since the 
quantities fj and Vj are very small compared to the total quantity 
of fibrinogen and the plasma volume of the experimental animal, the 
equation above can be simplified to*
F = C (Nj/Ng) because Zj/Vj + vp = °»
and Vx - Vp = i*0
VP
for all practical purposes.
Method
The experimental rahbits were injected Kith 25 to 30 uc of 
^-fibrinogen containing * to 8 mg of fibrinogen. The volume of
radioactive fibrinogen injected was usually 2 to 3 ml.
The radioactivity, N,, in one militer plasma Kas measured 
direct* by si^* r ^ v * *  a small volwae (-100 to .200 ml of
Plasma, placing it in a counting Vi., making it UP to 1, ml —
-Mnir the radioactivity in. a gamm with 0.1 H NaOH, and counting th
scintillation counter.
The specific activity, Ng (cpm/mg), measurements, on the other 
hand, were more involved. Usually 0.5 ml of radioactive plasma 
was taken and diluted to 6.0 ml with 5.5 ml of 0.005 M citrate.
The fibrinogen in the solution was then precipitated by adding
2.0 ml of 100 per cent saturated ammonium sulfate. After agitation, 
the precipitate was allowed to stand at room temperature for at 
least 30 minutes or in the cold for as long as 12 hours. The 
precipitate which formed during this time was separated by 
centrifugation at 2,000 rpm for 10 minutes. After discarding the 
supernatant, the precipitate was washed twice with 8 ml volumes of 
l/4 saturated ammonium sulfate. The supernatant from the last 
washing was removed as completely as possible in order to reduce the 
quantity of salt present, which may interfere with the action of 
thrombin on fibrinogen (25). After this treatment, the precipitate 
was dissolved in 4 to 5 ml of 0.005 M citrate and clotted with 0.2 ml 
of bovine thrombin solution (20 NIH units/ml), containing 6 to 10 ug 
of protein. The fibrin was collected as it formed on a glass rod 
and the fluid in the clot was expressed from it by rotating the glass 
rod and at the same time squeezing the clot between the rod and 
the test tube wall. The fibrin was then washed by first dipping 
the glass rod in 5 to 10 ml of 0.9 per cent NaCl and allowing it to 
stand for 20 to 30 minutes. The glass rod and fibrin were then 
placed in distilled water for another 20 to 30 minutes. When 
necessary, the fibrin was stored at temperatures below zero till the
time for analysis.
The specific activity, »2, of the fibrin was determined after
the fibrin had been dissolved in 40 per cent alkaline urea
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solution (40 per cent urea in 0.2 N NaOH). First the radioactivity 
of the fibrin-urea solution was measured directly by transferring to 
a counting vial 1.00 ml, accurately measured, of urea-fibrin solution. 
The concentration of fibrin in the urea was obtained from measurements 
of the density of the alkaline urea-fibrin using 1 cm optical path 
length quartz cuvets.
Fibrin prepared from purified fibrinogen solutions dissolved in 
alkaline-urea and measured within one to four hours of solution has 
an extinction coefficient, ^cm' at 282 mu wave length of 16.17 
(ie. the alkaline urea containing 1 mg of fibrin per ml of solution 
has an optical density of 1.617). Thus, the concentration, f, of 
fibrin in alkaline urea solution was determined from the optical 
density, e, of the solution and the extinction coefficient according 
to the equation f = e/l.6l7 (mg/ml). The radioactivity r& of the 
dissolved I131-fibrin was measured by counting 1.00 ml of the 
urea-fibrin solution in a gamma scintillation counter.
Having measured the concentration, f, and the radioactivity, ra, 
of the dissolved fibrin, the specific activity Ng is found from:
N0 = f/r (cpm/mg) d a
Knowing the radioactivity, N-^ cpm/ml), in the plasma and the 
specific activity N£ of fibrin, F, the concentration of plasma 
fibrinogen, is found from:
F * C (Nj/Ng)
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Test of the Isotope Dilution Method
a) Hie Extinction Coefficient of Rabbit Fibrin To determine
the extinction coefficient of rabbit fibrin, fibrin was prepared from
a purified fibrinogen solution of high clottability. The rabbit
fibrinogen was clotted with thrombin (6 to 10 ug) and dialyzed free
of salts, dehydrated by treatment with a (v/v 3 parts to 2 parts)
mixture of ethanol and ether and dried in an oven at 110°C for 24
hours. The bovine fibrin was prepared from a 1 per cent solution of
Armour bovine fibrinogen dissolved in 0.005 M sodium citrate, and
then treated exactly as the rabbit plasma. Weighed portions of dry
fibrin were dissolved in alkaline urea solutions and the extinction
coefficients were measured in the Beckman DU spectrophotometer at
282 mu wave length. Reasonable agreement was obtained between the
values of A  , found by Blcmback and Blcanback (96) and those 2o2 mu
listed in Table V.
b) Errors Arising from Occlusion of Other Plasma Proteins 
Blood serum and purified gamma globulin were labeled with I131-iodine 
and mixed with heparinized rabbit plasma. The fibrinogen was then 
separated, purified and clotted as described above and the radio­
activity in the fibrin was estimated. Table VI shows that small 
amounts of other serum proteins are occluded in the fibrin clot,
and that errors from this cause are, therefore, negligible.
c) Recovery of Fibrinogen from Plasma, 0.00? M Citrate, and 
Reconstituted Serum Measured amounts of purified fibrinogen were 
added and mixed with 0.005 M citrate, commercial reconstituted serum 
(Labtrol-Dade reagent) and to citrated and heparinized plasma.
DJJIVESSITY 
OF 
COLOnABO 
LIB
R
A
S
IfiS
uniTT.niiiP. 
nDT.ORABO
TABLE V
EXTINCTION COEFFICIENT OF FIBRIN IN ALKALINE UREA SOLUTION
AT 280 mu
Species Number of 
Measurements
Extinction Coefficient 
Mean and Range
Reference
Rabbit 5 16.09 
15.99 to 16.32
-
Bovine 3 16.59 
16.36 to 16.88
m
Bovine - 16.IT Blamback and Blomback (96)
1$ LoslOIo^ It
The extinction coefficient E = ------------- ; where,
282 1 cm (fn)
1 cm = light path length,
f = concentration of fibrin (10 mg/ml) in alkaline urea,
L°sioIo^ It= °p’fcical density ^  2®2 mu wave lenS’ttl,
I = incident light, oI = transmitted light."b
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TABLE VI
PER CENT OF CONTAMINATING TOTAL SERUM PROTEINS AND GAMMA-GLOBULIN 
FOUND IN FIBRIN CLOTS AFTER SEPARATION OF THE FIBRINOGEN FROM PLASMA.
AS IN THE ISOTOPE DILUTION METHOD
Sample No. Occluded total 
Serum Protein
Occluded xx 
Gamma-globulin
*Occluded Protein 
in mg/lOO ml
1 0.17# mm 12 mg
2 0.35 - 2k
3 0.30 21
Mean 0.27 - 19
k 0.5# 5 mg
5 - 1.1 11
6 *■ 0.9 9
Mean - 0.8 8
C^alculated from an initial plasma total protein concentration 
of T gram/lOO ml.
**Calculated from an initial plasma gamma-globulin concentration 
of 1 gram/lOO ml.
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The quantity of fibrinogen present initially in the plasma was 
measured by the isotope dilution method, and that present in the 
purified fibrinogen solution was determined from the clottability 
and the optical density at 282 mu in alkaline urea. A mean of 101 
per cent of the added fibrinogen was recovered as determined in 
33 analyses, and the precision of a single measurement was plus 
or minus 3.75 per cent. See Table VII.
The isotope dilution method was, therefore, considered satisfactory 
for quantitating the concentration of fibrinogen in plasma. It has 
a reasonably high precision, performs well as tested by recovery 
experiments, is sensitive, and does not suffer from the two major 
errors that beset the previous methods of measurements of fibrinogen, 
namely, losses of fibrinogen during its isolation and occlusion of 
contaminating proteins in the separated fibrinogen or fibrin. Further, 
it is not affected by anticoagulants such as heparin since these 
are removed during the fractionating process.
4l
TABLE VII
RECOVERIES OF PURIFIED FIBRINOGEN ADDED TO CITRATE SOLUTION, 
RECONSTITUTED SERUM AND PLASMA
Experiment
No.*
Initial
Solution
Fibrinogen
Concen­
tration
mg/ml
Fibrinogen
Added
mgs
Fibrinogen
Found
mg
Percent
Recovery
1 .005M Citrate 0 3-53 3-77 107
2 .005M Citrate 0 3.45 3-55 103
3 .005M Citrate 0 2.04 2.04 1004 .005M Citrate 0 3.89 3-91 100
5 .005M Citrate 0 1.74 1.81 104
6 .005M Citrate 0 3-82 3.76 99
7 Reconstituted
Serum 0 2.00 2.22 111
8 Reconstituted
Serum 0 3-95 4.08 103
9 Blood Plasma .89 1.69 2.55 99
10 Blood Plasma .89 1.69 2.47 06
11 Blood Plasma .89 3.38 4.08 98
Mean 101
*Mean of triplicate analyses standard deviation + 3*75#*
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Tracer Studies With I131-Pibrinogen in Rabbits: Standard Procedure
The experimental animals were white New Zealand male rabbits 
weighing from 1.6 to 3*7 kilograms. The young animals were 3 to 5 
months old, and the older animals were 6 to 12 months old. They 
were fed Purina Chow and fresh greens, and food and water were given 
ab libitum. Two weeks before, and during the course of the experiment 
the animals were housed in individual metabolic cages. For three 
days before and during the experiment their drinking water contained 
200 mg of potassium iodide and 1.8 grams of sodium chloride per 
liter to prevent I^^-iodide recycling and to encourage urinary 
flow.
The metabolic cages were of stainless steel with screened floors 
of mesh small enough to retain feces and yet permit the passage of 
urine into collecting receptacles. Daily collections of the urine 
and feces were made. The urine was collected in a polyethylene jar 
containing 20 to 30 ml of 1 per cent potassium iodide solution and
2 to 5 ml of toluene preservative. At the time of the urine 
collection, the cages were rinsed out with 200 ml of 1 per cent 
potassium iodide solution and the rinsings were added to the urine.
The feces were homogenized in a Waring blendor in 100 to 150 ml of 
distilled water containing a few crystals of potassium iodide. The 
homogenized feces were then transferred to a large counting bottle
CHAPTER IV
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and made to 300 ml with distilled water for counting.
Two to four ml containing 1.5 to k mg of I131-fibrinogen were 
injected, usually within one hour after iodination, into the 
marginal ear vein of the rabbits. The quantity of radioactivity 
injected was determined from the weight of the syringes before and 
after filling, less the residual volume determined from the activity 
washed out of the syringes by 0.1N NaOH. Duplicate standards for 
counting were prepared by diluting portions of the I131-fibrinogen 
solution with carrier serum and dilute NaOH solution. Following the 
injection, heparinized blood samples of 2 to 3 ml were withdrawn at 
accurately noted times over a period of 8 to 10 days. Some or all 
of the following measurements were made: hematocrit values, plasma
total protein concentration, plasma fibrinogen concentration, and the 
radioactivities of whole plasma, separated plasma fibrinogen and of 
the protein-free plasma. The plasma total protein concentration was 
determined by the CuSO^  method of Van Slyke (97), and the plasma 
fibrinogen concentration was measured by the isotope dilution 
method described above. The radioactivities of the plasma, urine, 
feces, and fibrin were all measured with a Nuclear Chicago well 
scintillation system consisting of a Model 1810 radiation analyzer, 
a 2-inch sodium iodide crystal, and a Model 183 binary scaler.
The number of counts of radioactivity in the samples was corrected 
for I131 decay by comparing them to radioactive standards prepared 
from the I131-fibrinogen injection material.
CHAPTER V
Tests of Iodine-Labeled Fibrinogen
A sensitive method for testing the quality of iodinated proteins 
is to measure the I131/ ^  count ratio of injected doubly-labeled 
plasma proteins over a period of time in experimental animals.
For this test, the I131-protein is injected intravenously into a 
donor animal that is at the same time started on a diet containing^  
C^-labeled amino acids. After the incorporation of sufficient C 
amino acids into the protein, the doubly-labeled protein is isolated, 
purified, and reinjected I.V. into a recipient animal. The decline 
in the specific activity of the doubly-labeled material is then 
studied and the changes in the I131/ ^  count ratio are calculated.
A second method is to use "biologically screened" ^-labeled 
proteins. This method is hased on McFarlane-s (MO observations 
that over-iodinated or altered proteins are removed rapidly Jrom 
the circulation. The method consists of injecting I.V. 
lied p-teina into a donor animal, moving -  of the donors 
plasma after 1 to 2 days, then partially purifying the protein under
study and transferring this or seme of the donors plasaa to a
. .lH+„ curves differ from thosesecond animal. If t h e  plaama radioaci.iv y
of the second animal given the unacreened I preparation, 
can safely be aas^ed that the donor animal has recoded and
the rest of the labeled molecules. The transferred protein or 
plasma is referred to as "screened" labeled protein by McFarlane (kk). 
If the labeled protein removed by screening is also rapidly 
catabolized, the body fluids and urine of the animal given the 
unscreened protein will early show higher levels of radioactivity 
unbound to protein than the body fluids and urine of the animal 
given the screened I^ 3 -^protein.
McFarlane (kk) has shown, using both of these methods, that for 
plasma albumin only certain levels of iodine substitution are 
permissible if the rL31-labeled albumin is to mimic the behavior of 
C -^biosynthetically labeled albumin or screened I131-albumin.
In view of this finding and because fibrinogen is less stable than 
albumin, various levels of iodine substitution were tested to 
determine the optimum level of iodination of fibrinogen. The 
criterion used was to compare the behavior of the in vivo screened 
I131-fibrinogen with that of unscreened rL31-fibrinogen. For this 
test, young rabbits were chosen since they eliminated the labeled 
material more rapidly than older rabbits.
Effect of Overlabeling Fibrinogen with Iodine
To study the effect of over-iodinating fibrinogen, fibrinogen 
was labeled at various levels of iodine substitution, which are 
defined by the l/P ratios. An l/P ratio of 1.0 indicates an average 
substitution of one iodine atcm per fibrinogen molecule. The l/P 
ratio of rL31-fibrlnogen was varied from 0.3 to 8.0. This material 
was then injected intravenously into animals of comparable size, 
age and sex and its behavior was chared with that of screened
I^ -^fibrinogen preparations with an i/P ratio of 0.5.
Figure 4 shows the results. The values of the screened fibrinogen 
are represented hy the small open circles and the top shaded area 
represents the range of variation of the values from three different 
animals given the same screened preparation. The stars, *, on the 
graph represent measurements made on rabbits given unscreened 
I131_fibrinogen with an i/P ratio of < 0.5. The lower points indicated 
by the dark dots and the more darkly shaded area represent measurements 
made on animals given unscreened I131 -fibrinogen with an i/P ratio 
> 1.0.
Inspection of the figure clearly shows that fibrinogen labeled 
with a mean of l/2 atom or less of iodine per molecule of fibrinogen
behaves as the screened preparations.
Figure 5 shows a comparison of optimally labeled I1 -fibrinogen 
(i/P < 0.5) and overlabeled ^-fibrinogen in older animals. Again, 
the top parts are the values of the optimum labeled fibrinogen, and 
the area represents the range of values obtained fro. these
animals. The lower parts represented by the +'s are the values of 
the overiodinated preparation, and the shaded area whieh includes 
them represents the variations in values obtained from three animals 
given I1 ^“-fibrinogen with i/P ratios of 1.0, 2.0, and 8.0.
On the basis of these experiments, the optimum level of iodination
,, -i jo atom of iodine per molecule of fibrinogen,rat chosen as less than 1/2 atom 01
Figure k. Comparison of values found when young rabbits were 
given I.V. "biologically screened" (o) and unscreened (*,#) I - 
fibrinogen. The stars. *, represent measurements made when optimally 
labeled (i/P < 0.5) II3l-fibrinogen was used and the dots, •, the
values obtained when overiodinated (j/j > 1*°) ^  Elation of theinjected. The shaded areas represent the range of variation
values found.
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131Behavior of Optimally Labeled I -Fibrinogen After I.V. Injection
Figure 6 shows the typical behavior of intravenously injected
I1  -fibrinogen in young and older rabbits. The data on each rabbit
is represented by two plots: one is the plasma radioactivity curve,
x(t), and the other is the plot of the radioactivity remaining
in the animal, the 1.0 - u(t) curve. On the ordinate is plotted
the logarithm of the fraction of the radioactivity injected which
remains in the animals, and on the abscissa is plotted the time of
the measurement. The graph shows the results obtained from rabbits
131779 and 786. Rabbit 779 was injected with screened I -fibrinogen s ®
and this is indicated by the subscript s. The plot of the data 
from the older rabbit is shown in the lower portion of the graph.
Analysis of the plasma activity curve by standard methods shows 
that the x(t) curve is usually fitted by an exponential function of 
time x(t) = cie“alt+C2e”a2t. The smooth curve, x(t), drawn by 
means of this equation, with the constants determined by graphical 
analysis, closely Ascribes the data during the experimental period, 
as shown In the figure, both for the older animal 786 and the young 
rabbit. To allow comparison of the experimental data in differen 
animals, the initial samples were assigned unit radioactivity at 
zero time (10 minutes after injection of the labeled fibrinogen), 
and the radioactivities of subsequent samples were plotted as the
Figure 6. Topical "behavior of optimally labeled 1^  -fibrinogen 
in young and older rabbits after I.V. injection. The top two curves 
are those of the young rabbit and the lower two of the older rabbit.
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logarithms of the fractions of the amount in the initial sample.
The constant C.^ and the slow exponent, a^ , of the linear portion 
of the curve were obtained by extrapolating the tail of the curve 
to time zero to obtain the zero intercept, C^ , and from the half- 
life of the curve and the equation a^  = .693/t-l/2. The half-life 
is read directly from the graph, and is the time corresponding to 
C^ /2. The second constant, C2, and the faster exponent, ag, were 
found by subtracting the fitted values of C1e"alt from the curve 
fitted to all the experimental data, and plotting this difference 
between the two curves against time. In most cases this difference
n "Jjcurve was linear* and could be fitted by a function, C^ e 2 , where 
C2 is defined by 1 - C^ , and ag is defined by 0.693/t-l/2, where 
t-l/2 is the half-life of this faster slope. Occasionally 
extrapolation through this difference curve to zero time led 
to an intercept that was less than 1-C^ . Then subtraction of 
the curve defined by C2e“a2t from the difference curve left a small 
remaining curve that could be fitted in the same manner by a 3rd
exponential C^ e a3  ^•
Table VIII summarizes the values for the constants, C^ , C2, CL,i/J cir
a^ , a2, and & , and it can be seen that in two and possibly a third 
young rabbit the x(t) curve is a three exponential curve. The 
values for ^  range from 0.68 to 0.90 in the older rabbits and from
O.57 to 0.82 in the young animals. The values for the linear slope 
a1 range from 0.273 to 0.396 in all the experimental animals. The 
values for the biological "half-life" are also given and range from 
I.96 to 2.54 days in the older and 1.75 to 2.5*1- days in the
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young rabbits.
Th® Radioactive Breakdown Products in the Plasma and Tissue Fluids 
It has been shown "that the radioactive breakdown products of
131I -albumin given intravenously to rabbits consist of more than 
80 per cent inorganic iodide and the remainder of ama.11 organic 
metabolites, (67), (98). This is probably also true for 
fibrinogen (46). These breakdown products are distributed in a 
volume of 8 to 10 times the plasma volume and are rapidly excreted 
(67). Figure 15 (see page 80 ) shows the behavior of the total 
quantity of the radioactive breakdown products represented by the 
curve z(t). The points on the z(t) curve are expressed as decimal 
fractions of the total radioactivity injected. These values were 
calculated from the measurements made of the radioactivity in the 
plasma which was not precipitable with 10 per cent trichloroacetic 
acid multiplied by the distribution volume of the breakdown products. 
From the figure it can be seen that maximum, retention of the break­
down products in these animals occurred about 12 hours after the 
injection. When the unbound radioactivity was measured in the 
plasma at this time it accounted for only 1 to 2 per cent of the 
total radioactivity in the older animals, but in seme of the 
younger it was found to make up 4 to 6 per cent of the total
activity.
Excretion of the Radioactive Breakdown Products
The vtpper curves in Figure 6 show the disappearance rate of 
the injected radioactivity from the animals as measured from t 
activity in the excreta.
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The curve is a plot of the amount injected, normalized to
1.0, minus the cumulative excretion of the radioactivity excreted, 
u(t) • The 1 - u(t) curve has a slope a^  and is seen to parallel 
the slope, a^ , of the plasma activity curve. The radioactivity was 
excreted rapidly with little or no delay as shown by the plots of the 
cumulative rates of excretion, u(t), given in Figure J. Table IX 
summarizes the values for the daily excretion of breakdown products, 
and it can be seen that on the average 15 to 30 per cent of the 
radioactivity injected appears in the urine during the first day 
in animals exhibiting no urine retention. The majority of the 
radioactivity excreted was found in the urine and only very small 
amounts in the feces. After the first day or two, the curve 
describing the excretion of radioactive breakdown products is given 
by u(t) = 1.0 - Ke""aut where K is some constant.
Extravas cular -Fibrinogen
The extravascular rL31-fibrinogen cannot be measured directly, 
but may be calculated from measurements of x(t), the plasma activity 
z(t), the radioactive breakdown products activity, and u(t), the 
fraction of the injected radioactivity excreted up to a given time, 
t, since by definition y(t), the interstitial I131-fibrinogen is 
equal to 1.0 - x(t) - z(t) - u(t). Good measurements of the total 
plasma and urine activities are readily made, but the amount of 
radioactivity in the plasma due to breakdown products is low and 
accurate measurements of z(t) are difficult to make. Hence, the 
values found for the interstitial fibrinogen determined in this 
manner are only approximate. Figure 8 shows the results 
calculations of the total interstitial activity in one rabbit.
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Figure 7* Plot of the cumulative rate of excretion of radio- 
active breakdown products. The stars, *, represent the observed 
values and the smooth curve the values calculated from equation 16.
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TABLE IX. In this table, * = the time of urine collection 
(the morning following the I.V. - injection of I^l-fibrinogen) isexpressed as a fraction A.
58
< p
p
8
+
00
<
+
<1
+*
v o
LTN
<
+
-4*
<
+
OO
<
+
OJ
<5
rH
8•H
-P
I
•P•rl
1
H  H
00 OJ 
00 ON
Cr— 00
CO OO o j 
On ltn on I • 00 •
ON LTN 00 ON CVJ 
LTN ON OOOO H  
CO CO ON 00 ON I I
. 00 
On H
t— oo
H00 00 CO
OO LTN 00-4* 00 
ITN ON C— VO OJ 
t*1— t*— C*1— OO
OJ OJ ONOOOJVOVO 
t— o o o n o  oo on on 
vo  t - v o  b—v o  vo
ON oo ON ITN t—00 fc— 
vo  H O N IA H C X ) 
ltnvo vo  ITNVO v o  ltn
IA O J H O N H  W 4 -Q> ° ^ ° *£>Jj* LTN-4- LfN LTN^t
vo ooco H
ON ON CO VO o j co  oo H OJ oo H oo oo oo
o  o
o  OOVO OJ On 
o  O N O O IA IA  
OJ O  OJ ‘rH rH
CO
a
1
<D"d
ONVO ON u~\ 
C—VO OD b~ b -
o  o
P}<2.
O  H  H
03 On • • I lilt
l f \  OJVO oVO OJ oo
_ .CO ON ON OnII • I * * | •
co OJ tr\ is-O-3- 
O  LTN OOOO H  ON 
00 CO CO CO ONCO* I I
OO OJ oo ITN
ON VO ITN LTN
IS- 00 CO COI I • I * • I •
O  OJ CO 
OJ ITN oo LTN ON ON tr— — b— C-— t— b— CO
t— ON ON OOOO t'— O  O
.c o .cq .oj .t r .c n  H  o  oj
vo  vo VO VOVO
03
a
1
t«D
O J O J Q O Q O J H O O
co co  VO O  CO ON O
LTN Lf\ LTN LTN LTN LTN ITNVO
CVJ H  ir> CO O  O  O
oo -=J* -3* oo^ * -=i*
b -v o  OOVO t— o  O  LfNH HCqtA t-VO £7OOJOJHHHCVJCVJ
VD H  LfN-^ OOVO 
VO t— ON t— ON ON CO vo
Crt (Q rri tQ 03 W
4 - V O  O  H  O n 00 IS*
CU CU CQ 0D CO t“ <2 . 92.t— t— t— Cr— C— t— C— t—
DWTVwmj-y 
m 
COLORADO 
nBEfiJlJss
Figure 8. Extravascular I 3 -fibrinogen: The dots,
represent the values found from y(t) = 1.0 - x(t) - z(t; 
the smooth curve those calculated from equation 17 •
CHAPTER VII
Model Describing the Distribution and Catabolism of Fibrinogen
It has been shown that fibrinogen is made in the liver (99)
(100) by the liver parenchymal cell (lOl). The fibrinogen, newly- 
synthesized, is then transferred to the systemic circulation either 
by the hepatic lymphatics (102) (103) (104), or by direct transfer 
into the blood stream (105) (106). Whatever the mode of transfer, 
the fibrinogen must reach the circulation rapidly and once it has 
entered the circulation, it is further distributed throughout the 
blood stream. From there, the fibrinogen passes to the interstitial 
fluids by transcapillary transfer, and then returns to the venous 
circulation mostly via the lymphatics. Evidence for this was 
obtained by Lewis and Furguson (35) who recovered r^-fibrinogen 
given intravenously from the thoracic duct lymph. Additional 
evidence is found when lymph is treated with thrombin and fibrin 
clots form. Fibrinogen is also continuously catabolized. The 
catabolism of fibrinogen may occur either directly by fibrinogenolysis, 
or, after fibrin formation, by fibrinolysis. Some of the views on 
the modes and sites of fibrinogen catabolism have already been 
summarized. In healthy animals, the rate of fibrinogen synthesis 
must equal the rate of fibrinogen catabolism and the rate of fibrin 
deposition must equal the rate of removal. Otherwise a net depletion 
or accumulation of fibrinogen and fibrin would occur.
S^le Mod£i£ Pescrlblnfi the Behavior of Fibrinogen and I^-Fibrinogen
The behavior of fibrinogen as described above may be presented 
diagrammatically using a compartmental model as in Figure 9 and 
assigning varying rates of transfer and catabolism to fibrinogen.
The rates can be considered as velocities requiring a definite time 
for a molecule of fibrinogen to reach its destination.
Model I in Figure 9 describes the fibrinogen system. Fibrinogen 
made in the liver is shown to enter the blood compartment in which 
there is x grams of fibrinogen. Here it is rapidly mixed. Fibrinogen 
passes into the interstitial fluids at the rate r^ x and is returned to 
the plasma at the rate r^ where y if the total interstitial fibrinogen. 
Fibrinogen also passes to catabolic sites, v, at the rate r^ x and to 
tissue fibrin, w, at the rate r^ x. The fibrin in compartment w is 
then shown to be depolymerized at a rate r^ w and transferred to the 
same breakdown site, v, as that for fibrinogen where both fibrinogen 
and fibrin monomers are broken down further. All the r’s have 
dimensions of day ^ *« The model thus suggests two possible catabolic 
pathways for fibrinogen and the rates imply a dynamic system which 
can be subjected to kinetic analysis by using I -labeled 
fibrinogen.
The system describing the behavior of injected I 3 -fibrinogen
is presented as Model II in the Figure 10. In this, the liver
compartment has been deleted and two others, the radioactive break- |
down products and the I131 excretion compartments, have been added.
The total radioactivity in each compartment is designated as a
_ Q +~4-ni r^l-fibrinogen radioactivityfunction of time. Thus, the total
i v(+ 1 and that in the interstitialat time, t, in the plasma is x(tj ana ^  x
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Figure 9. Model I: Schema describing the distribution and
transfer of fibrinogen in the living animal in the steady state.
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fluids y(t). The I ^-fibrin radioactivity is w(t) and that in 
the catabolic compartment v(t). The radioactivity of the breakdown 
products in the tissue fluids is z(t), and the cumulative radio­
activity passing into the excreta is u(t).
Since the rates represent the fractional rate of removal of the 
labeled material the product r^ xCt), for instance, defines the flux 
of fibrinogen radioactivity into the interstitial fluids per day.
Such a system can be described by a series of differential equations. 
Before attempting to find the solutions for these, analysis of the
1I31-fibrinogen data may suggest a simpler model "which will adequately 
describe the observed data.
CHAPTER VIII
Analysis of the Radioactivity in the Various Compartments
Examination of the Plasma Radioactivity and Fibrinogen Concentration
Figure 11 shows a plot of the plasma activity, cpm/ml, (the
top curve) and the IT^ -^fibrinogen specific activity, cpm/mg, (the
lower curve), in rabbit 781 . Below the two curves are plotted the " s
plasma fibrinogen concentrations at the time of blood sampling.
These findings are typical in rabbits showing fluctuations in the 
concentration of plasma fibrinogen.
The most striking feature of Figure 11 is the effect that changes 
in the plasma fibrinogen concentration produce on the specific 
activity curve. Notice that as the fibrinogen concentration rises, 
the specific activity curve falls more rapidly than the plasma 
activity curve, and conversely, as the fibrinogen concentration 
falls the rate of decline of the specific activity curve is decreased. 
However, the fluctuations do not affect the plasma activity curve, 
uhioh as noted above is described by a 2 or 3 exponential equation.
A possible cause for these observations is that the ^-fibrinogen 
is selectively removed fran the circulation. But since it^ 
as biosynthetically labeled ^ -fibrinogen and screened I131- 
fibrinogen, such a process is very unlikely. Other causes of th 
findings are that the ^-fibrinogen system behaves as either an 
unsaturated first order process or a volumetric clearance system.
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Figure 11. Fluctuations in fibrinogen concentration and their 
effect on the plasma activity and I^-fibrinogen specific activity 
curves.
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Both types of processes will now be briefly discussed.
Unsaturated I^-Fibrinogen Capillary Transfer System 
The transcapillary transfer system is not difficult to conceive 
if one assumes that "pores" are available for the passage of 
fibrinogen across the capillary wall. If many pores exist in the 
endothelial wall, these would be difficult to saturate with fibrinogen 
molecules since capillaries permeate almost every tissue. In fact, 
it has been estimated that the total endothelial area of the 
capillaries of human muscle is about 6,000 square meters (107), 
while the fibrinogen concentration in the plasma ranges from 300 to 
500 mg per 100 ml. If the ratio of 1 ^ -fibrinogen to unlabeled 
fibrinogen molecules was halved by doubling the concentration of 
fibrinogen by new synthesis, by the law of mass action, the total 
number of molecules colliding with the endothelial wall would 
double, but the fraction of I1 1^-fibrinogen molecules colliding in 
unit time would be unchanged. Such an effect would maintain the 
rate of I1 1^-fibrinogen transfer the same as it was before the 
increase in fibrinogen concentration. Thus, the plasma radioactivity 
curve would be unaffected by the fluctuation in fibrinogen 
concentration.
b) The Unsaturated Catabolic System An unsaturated catabolic 
system might consist of a large number of catabdlic sites. These 
could be distributed either intravascularly or extravascularly. When 
plasma containing rL31-fibrinogen is removed from healthy experimental 
and incubated at 3?°C for 2k hours, no increase in the 
non-precipitable radioactivity is observed, which excludes t
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the presence of an enzyme in the plasma (in health) that breaks
131
down I -fibrinogen. Evidence in favor of vascular endothelial 
catabolic sites has been obtained. Thus Copley and others (29) (103) 
have shown that fibrinolytic activity is closely associated with the 
capillary wall. Copley maintains further that this fibrinolytic 
activity is essential to maintain the patency of the capillary wall 
and to remove any fibrin deposited on the endothelial wall. At the 
present there is insufficient evidence about the nature of the
extravascular catabolic sites if they occur.
c) A Volumetric r*~ ^-Fibrinogen Clearance System A volumetric 
capillary transfer system might be due to vesicle transport system 
occurring in the capillary endothelial cells. Each pinocytotic vesicle 
would "drink" a certain volume of plasma and the vesicle would be
passed across the capillary endothelium. Thus a given fraction of
"^ -fibrinogen would be passed across the capillary membrane, which 
would be independent of the fibrinogen concentration. Electron 
microscope studies of the endothelial cells have shown the presence 
of intracellular vesicles of about 650 A in diameter. These vesicles, 
in tightly packed layers, are seen to face both the perivascular 
space and the capillary lumen (109) (110) (Hi). Close examination 
suggests that many of them open at the perivascular surface of the 
endothelial cell membrane. The transport of fibrinogen thus may 
depend on innumerable small volumes of plasma being taken up in 
vesicles by plnocytosls and extruded ou the perivascular side of the
cell.
Against the pinocytotic theory two points can be advanced.
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First it is not clear whether the pinocytotic process occurs 
sufficiently rapidly to explain the rate of transcapillazy passage. 
Second, it implies that any proteins in the pinocytotic vesicles 
would be cleared at the same rate from the plasma. On present 
evidence this does not appear to be true.
<l) The Volumetric Catabolic System This would occur by 
vesicular transport to a catabolic site, but at the present evidence 
in favor of this is lacking.
Examination of the Radioactive Breakdown Products Released by the 
Catabolism of I^^-Fibrinogen
a) Catabolism Via Fibrin Formation If formation of fibrin 
is prerequisite to fibrinogen breakdown and occurs outside the 
vascular compartment as shown in Model I, this can be closely 
approximated by forming an T^ "^ -fibrin blood clot subcutaneously.
In this manner some insight into the mechanism of fibrinogen 
catabolism may be obtained.
I131_fibrinogen mixed with rabbit citrated blood was 
recalcified and the mixture immediately injected subcutaneously.
This produced a film blood clot containing radioactivity which 
could be measured at the site of the clot nith a scintillation probe. 
®ie measurements made with the probe could then be compared wi
the excretion of the breakdown products.
Figure 12 shows the results of such an experiment. The top 
curve represents the radioactivity remaining in the animal and was 
obtained by subtracting the fraction of the total activity excreted 
from 1.0, the initial radioactivity in the clot. 1b. lower curve
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is the radioactivity measured at the site of the clot with the
probe, which disappeared over 7 to 8 days. Measurements of the
plasma activity during this time showed that it was not precipitable
by trichloroacetic acid, and, therefore, the clot was broken down
—  with the release of radioactive breakdown products unbound
to soluble protein. Though the radioactivity began to disappear
from the clot almost immediately, some time was required for the
radioactivity to appear in the urine. This indicates that if
i131 -fibrinogen is broken down via extravascular fibrin formation,
a lag in the excretion of the breakdown products might be detectable
131in the animals given I -fibrinogen intravenously.
Figure 13 compares plots of the excretion of the radioactive
breakdown products in experimental animals receiving I131-fibrinogen
131intravenously and subcutaneous I -fibrin blood clot. Wo lag in
131excretion is apparent in the animal given I -fibrinogen I.V. On
131the basis of these findings, it is concluded that I -fibrinogen 
before being catabolized does not pass through an extravascular 
fibrin compartment, w, and this is excluded from Model II.
b) Existence of the v Compartment, The Breakdown Compartment 
If a breakdown compartment, v, exists, according to Model II, the 
I^"3^"—fibrinogen would be transported to this at a rate r^ x(t), 
catabolized, and the breakdown products released at the rate 
rgv(t). This process is time consuming and a delay in the excretion 
of radioactive breakdown products should be observed if it is m  
operation. TO test the importance of the v compartment, Figure 7 
compares a plot of the observed rates of excretion with valnes
CUMULATIVE 
URINARY EXCRETION
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Figure 13- Cumulative excretion °™aproduSf in the urine of rabMts g i v e n  I^-fitomogen I.V. and
those with a subcutaneous I^-fibnn blood clot.
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calculated on the assumption that breakdown occurs in the blood 
stream. Agreement is good and thus evidence that the v compartment 
in Model II, if it exists, is small and can be neglected.
The i131 -fibrinogen model in health thus may be simplified 
to a four compartment model by omitting the fibrin compartment, w, 
and the breakdown compartment, v, from Model II, though this may 
not be true in disease. The observations first described in this 
chapter indicate that the rate constants, r^ , r^ , and r^  are first 
order whatever their underlying physiological basis; k^  is also 
first order and is the fractional rate of excretion of the radio- 
active breakdown products. It ranges between 2.0 to 3*0 day (67). 
The four compartment model will now be presented diagrammatically, 
the mathematical equations will be written, and the predictions of 
the equations will be tested by experiment.
CHAPTER IX
Model Describing the Behavior of I -Fibrinogen
Model III in Figure 1^ , consists of four compartments only, 
the x(t), y(t), z(t), and u(t) compartments -which have already 
heen defined. The arrows indicate the direction of flow of I131- 
fibrinogen from the vascular compartment.
Mathematically, Model III is described by the following 
differential equations:
1) dx(t )/dt = r^t) - (rx + r3) x (t)
2) dy(t )/dt = rxx(t) - r^Ct)
3) dz(t)/dt = r3x(t) - Ts^ z(t)
4) du(t)/dt = kj-z(t)
Solutions of the Differential Equations Describing the Model
Equations 1 and 2 in operator form become equations 5 and 6:
5) r  D + (r^ + r^) 3  x(t) = r^yCt),
6) (D + rg)y(t) ■ r^ xCt).
Solving equation 6 for y(t), y(t) = rjx(t)/ (D + rg), an 
substituting y(t) into equation 5 one obtains equation T.
T) (D + r2) | >  ♦ (rx + r3> ]x(t) - r ^ t )  vhicb simplifies
8)1" D2 + (r. + r2 + r3) E + r2r 3
differential equation with the Equation 8 is a linear homogeneous diffe
. . m real and distinct. It
roots of the auxiliary equatxon, ± 2
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131I- FIBRINOGEN MODEL
III
Figure 
behavior of
ll4-. Model III: Simplified model describing the
jl31—fibrinogen in the living animal*
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has the general solution, x(t) = C1emlt+C2em2t. Letting =
-a^  and = -a^  where both a‘s axe greater than zero to ensure that
the rates, r, are also greater than zero, then x(t) becomes
9) x(t) = C^ e ^^-K^e a2^ . This agrees with the form of the 
plasma activity curve.
The solutions for the rate constants, r^ , r2, and r^  will now 
he calculated from equation 1 and the relations “between the roots 
of the x(t) curve, and the initial and final conditions.
From equation 1 and by differentiating equation 9, equation 10 
is obtained.
10) dx(t)/dt = -C1a1e“alt - - r^Ct) - + r3) x(t).
-0From initial conditions that at t = 0, y(0)=0, x(0)=l, and e =1, 
equation 10 *becames equation 3-1*
11) rx + r3 = C1a1 + C2a2 and r± = + C2a2 - r^
Since the amount of radioactivity injected has been normalized to
1.0, as time, t, increases x(t) goes to zero and u(t) to 1.0. 
Therefore, the total quantity of I131-fibrinogen broken down at the 
rate r cannot exceed^nityi ie, r3 - 1.0. For a two
exponential x(t),^/x(t)dt = 0 ^  + V V  804 ^  fra0ti0nal
rate r3 id found by the reciprocal of this value.
12) rQ = 1-- -—
3 0^  + Og/ag
The solution for r£ is found free, equation 12 and the relation
between the roots of the auxiliary equation and the x(t) equation.
_ a,a„/r,. Substituting this into If MjBg = a,a2 = r£r3, then r2 ^ 2/ 3
equation 12, the solution for r, is found to be,
13) r2 = a2Cx + a-iV
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The values for the rate constants r , rg, and r^  can he found from 
the C's and a*s which are obtained from the experimental x(t), the 
plasma activity, by graphical analysis and have been presented in 
Table X (see page 82).
Solutions for y(t), z(t) and u(t)
Taking x(t) as a two exponential function the solution for
equations 2, 3, and  ^can be found by standard methods. Only one
solution will be carried out in detail and the other solutions
will be given.
Setting equation 3 in operator form, it becomes,
1^ ) (D + kj. )z(t) = r^ x(t) = r^Cc^”8!1' + Cge a2t). Equation 1^
is a non-homogeneous linear differential equation and can be solved
by the method of undetermined coefficients. The general solution of
equation ik is z = z + z where zc can be obtained at once fromc p
the values of the root of the characteristic equation, which for
equation lk is -k^ . Hence, the complementary function for lb,
z , has the following general solution, 
c’ N _ -k_t15) z - cze 5 •
A + ■R«“aptTo find the particular solution zp, let zp - Ae 1 + *e
which has a first derivative, « -(Aa^- 1 + Ba2e 2 )• By-
substituting Zp for *(t) and ^  for D in equation jA and solving
for A and B, it is found that,
A - r A ( y x )  B = r3°2{k5-a2)- Sin0e the SOl“ti°n *" Z<t> ’
s + z the solution for z(t) can he obtained by substitution and 
c p
solving for Cz and is,
16) *(t) - Ate'8!* - e'V) +
T8
Solutions for equations 2 and 4 can be obtained in a similar 
manner. The solution for y(t) is given by equation 17,
17) y(t) = G1(e”alfc - e r2t) + G2(e"a2^  - e-1^ )  where 
G! " r1C1/(r2-a1) and G2 =
The solution for equation 4 is given in equation 18,
18) u(t) = 1.0 - kj. J^ A/a^ e + B/a^ e a2^  - (B+A)/k^ e ^ 5 
where A and B are the constants described for z(t) in equation 16.
CHAPTER X
Test of the Model: Comparison of the Observed and Calculated z(t),
u(t), and y(t) the Tracer Rate Constants in Young and Older Rabbits
Agreement between x(t), the plasma activity curve, found 
experimentally and that calculated has already been mentioned above. 
Figure 6 shows the comparison. The experimental values are represented 
by the dots, and the fitted curve by the continuous line.
Comparison of Observed and Calculated z(t)
Figure 15 compares the observed z(t) and z(t) calculated from 
equation 16. The measured z(t) values are plotted as fractions 
of the total activity injected. The plots in Figure 15 are for 
rabbits number 779s, the young rabbit, and number T9T, an older 
rabbit. Since the measured count rate for the plasma unbound r13 - 
racioactivity ranged from 10 to 50 counts per minute against a back­
ground of 20 cpm, the accuracy of the measurements is not great.
Prom the figure it can be seen that the calculated and observed
z(t) agree reasonably veil*
Comparison of Observed and Calculated u(ti
in Figure T, the measured and the calculated rates of urinary
excretion of the breakdown products are plotted. The al 
u(t) was found from equation l8 for rabbit jQk, is based on 
assumption that the fibrinogen is broken down in or very near the 
vascular c o g e n t  vith the mediate release of the radioactive
80
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Figure 15. Comparison of Values for z(t) calculated from 
+ . those obtained experimentally. The calculated
X e  s ^  s £ £  S  the continuoufhlac* line and observed values
by the broken line.
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breakdown products, which then pass directly into the breakdown 
products compartment. The agreement between the calculated and the 
observed values is excellent.
Comparison of Observed and Calculated y(t)
Figure 8 compares for rabbit 779 the calculated y(t) curves
obtained from equation 17 and that obtained from the experimental
values were y(t) = 1.0 - x(t) - z(t) - u(t). The observed values
of y(t) are represented by the dots and the broken line, and the
calculated values are represented by the smooth curve. The
observed and calculated values agree reasonably well though as
noted below the measurements of z(t) are only approximate.
Since the agreement between the observed values and those
calculated from the equations derived from the model is good,
131Model III is accepted as describing the behavior of the I
131fibrinogen in vivo. Further since by all tests, the I -fibrinogen 
behaves similarly to the animals native fibrinogen, the rate constants, 
the r’s, can be used to determine the fluxes of the native fibrinogen. 
Before this can be done, the r’s must be determined by equations
11, 12 and 13 from the tracer data.
The Fractional Rates, rx and ry  of J^-Fibrinogen
The values for the fractional transcapillary transfer rate, 
r , vere calculated from equation 11 for each experimental animal 
L  are listed in Tahle X. In the older animals these values range 
ft- 0.33 to 1.03 day' 1 uith a mean of O.TT day'1. In the young 
rabbits, hovever, the values calculated uere greater, ranging from 
0.81 to 2.20 d^ 1 vith a mean of l.tt day'1, in the young
8a
FRACTIONAL RATES OF I131-FIBRINOGEN 
CALCULATED FROM EQUATIONS 11, 12 AMD 13
TABLE X
Rabbit
No.
Transcapillary 
r.j== day"1 r2= day-1
Catabolic 
r^ a day"1
Older Rabbits
179b
l8lb
151795a
787
797
786d
.71 
1.01 
1.03 
.32 
• 94 
.63 
.77
2.09
3.02
6.90
1.70
9.00
3-^ 5
7.50
.44
.49
• 37 
.34 
•33 
.36
• 30
Mean •77 4.80 .375
Young Rabbits
725 
724a
726 
780s 
784d 
78ls 
779s 
788s 
787
.81
2.05
1.51
1.08
1.58
1.58 
1.28
.92
2.20
5-27 
5.79 _*
-*
5-72
2.85
3.30
2.29
6.00
.47
.35
M
M
.49
.52
.4o
.42
Mean 1.44 4.46 .45
* Rabbits had 3 exponential x(t) curves thus r2 is not defined
"by equation 13*
a = rabbits given screened labeled fibrinogen; a, b, and - 
rabbits given the same labeled fibrinogen prepara
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rabbits the fractional transcapillary rate of I1^ 1-fibrinogen is 
almost twice as fast as that calculated for the older rabbits.
The values for r^ , the fractional catabolic rate, calculated 
from equation 12 are also listed in Table X. Again note that the 
young rabbits have a faster r^ . In the young animals r^  ranges 
from 0.35 to 0.52 day"1 with a mean of 0.45 day-1 compared to the 
range of r^  found in the older rabbits of 0.30 to 0.49 day 1 with 
a mean of O.375 day”1. Though the fractional catabolic rate is 
faster in the young rabbits, the difference is not as large as that 
seen in the transcapillary transfer fractional rate.
Since the I1 1^-fibrinogen injected into these animals has 
been shown to be as near to the native fibrinogen, according to all 
the tests performed, these values will now be used to calculate the 
fluxes of fibrinogen in these animals.
CHAPTER XI
Results
Plasma Fibrinogen Concentration
The Pi fl,amfll fibrinogen concentration fluctuated in some animals 
and remained reasonably constant in others. In a few animals the 
fibrinogen concentration doubled in 24 hours but then returned to 
noimal within 24 to 48 hours. In most of the rabbits, however, only 
gynaii fluctuations were observed. The mean plasma fibrinogen con­
centrations for each experimental animal over the course of the 
experiment are listed in Table XI. The values found range from 
2.40 to 4.35 mg/ml with a mean of 3*44 mg/ml in the entire group
of animals.
Total Fibrinogen in the Plasma
The total plasma fibrinogen was calculated from the measured 
volume and the mean plasma fibrinogen concentrations. The 
values are listed in Table XI and are higher to the older rabbits.
For instance, in the older rabbits the total plasma fibrinogen ranged 
from 260 to Wtt mg with a mean’ of 376 mg, compared to a range of 210 
to 318 mg with a mean of 2>*5 mg in the young rabbits. This difference 
is primarily the results of the smaller plasma volume of the young 
rabbits, from their smaller size. When the plasma fibrinogen per 
kg hody weight is determined, the difference was not as large. In 
the older animals, the range was from 76 to 122 mg/fcg with a mean
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mof 106 mg/kg, compared to a range of 9  ^to 139 mg/kg with a 
mean of 118 mg/kg in the young rabbits.
The Total Interstitial. Fibrinogen y(t)
The total interstitial fibrinogen, y(t), cannot be measured 
directly but was calculated from the following equations,
19) r^t) = r^Ct), from which 
y(t) = rxx(t)/r2,
20) y(t) = r^ xCt) (D-^ /d^  + Dg/dg) (112).
Equation 19 is applied when x(t) is a 2 exponential equation,
and equation 20 when x(t) is a 3 exponential equation. The values
for D , D , d_ and dp are calculated from the 3 exponential x(t)
1 2 1 2
as described elsewhere (112).
The values for y(t) calculated from these equations are listed 
in Table XII which shows that the total interstitial fibrinogen in 
the older animals ranges from 11 to 39 mg/kg ^ h  a mean of 22 
mg/kg, but in the young rabbits was somewhat larger, with a mean of
1*2 mg/kg and a range of 21 to 59 mg/kg*
The total interstitial fibrinogen can also be expressed in terns
of the 6xtravascular to vascular fibrinogen ratio. Table XII shows
that this ratio in the older rabbits ranges from 0.10 to 0.3* with
a mean of 0.20, and in the young rabbits ranges from 0.15 to 55
uith a mean of 0.36. *  parable °f
extravascular to intravascular albumin is about 1.5 (US). «»»,
fibrinogen must be distributed in much less of the interstitial
fluids than albumin*
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The Distribution and Fluxes of Fibrinogen
Analyses of the I131 -fibrinogen data have shown that the
transcapillary transfer and the catabolic systems were not affected
by fluctuations in fibrinogen concentration, which are defined in
the symbols previously used as x(t)/V where x(t) is the total plasmaP
fibrinogen at time t, and is the plasma volume. Flux to the 
interstitial fluids over the interval t± to is given by
r1
tl
and the flux to the catabolic sites as
r ir3 I xCtJdt/Ctg-^), 
*1
Where the time interval is measured in days. These fluxes may be 
pictured as the fractions of the volumes of plasma r ^  and r^, 
"cleared" per day to enter the interstitial fluids and catabolic
sites respectively.
The l*ansca£illar£ and Catabolic Jluxes of I^ brinogsn
Average values for the transcapillary flax, rf, are listed in 
Table XI, which shows that a mean of 81 mgAg/day of fibrinogen in 
the older aaimals plasma passed to the interstitial fluids compared
to a mean of 171 mgAg/day in the younger animals.
Table XI also shows that a mean of 39 mg/Wday was catabolized
*y older rabbits, ccmpared with a mean of 56.5 m g W «  *  *•
young rabbits•
CHAPTER XII
Discussion
Preparation and Test of I131-Fibrinogen
a) Preparation of Fibrinogen The purity of the fibrinogen 
used for labeling is important since iodination will label all 
proteins present. If the half-lives of the other proteins are 
longer than that of fibrinogen their presence will extend the 
apparent half-life of fibrinogen. Thus, suppose that the 
iodinated fibrinogen contained 10 per cent albumin (half-life 8 
days) and 90 per cent fibrinogen (half-life 2 days). Then, after 
eight days, the albumin radioactivity in the circulating plasma would 
make up 50 per cent of the total plasma radioactivity, and the 
values for the slow part of the I^-fibrinogen curve described by
C e'V 1 would be obtained that were much too long.
1 b) Tests of the ^-Fibrinogen These tests, with the results
of their application, have already been described. These studies 
confirm those of McFarlane («) in showing that to obtain X 
fibrinogen suitable for tracer studies in vivo, the iodine atom to 
protein molecule ratio must be l/2 or less. Bis has only been 
appreciated within the last 2 years, and makes the results of the
... -rlSl^ i-brinogen of uncertain significance, most earlier studies with I -fibnnog
. . ~ -fM-hrdnoeen is shown in Figures 4The effect of overiodination of fibrinogen
=™tions were used to calculate the fibrinogen and 5* If such preparations
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fluxes too high values would he obtained.
In previous studies with tracer-labeled fibrinogen information 
about fibrinogen concentrations, plasma volume, the constants of the 
x(t) curve, and the i/p ratio is all or in part lacking. In 
studies using biosynthetically labeled fibrinogen the disappearance 
of the radioactivity was obtained from specific activity measurements, 
which are affected by fluctuations in fibrinogen and by reutilization 
of the or -labeled amino acids. In these studies half-lives 
for labeled fibrinogen of 53 to 86 hours were reported (36) (39) (^ 0  
(45) but fibrinogen fluxes and distribution cannot be calculated.
In studies with I131 -fibrinogen the disappearance rates of 
injected radioactivity, for the most part, were obtained from 
specific activity measurements. The I131-fibrinogen was 85 to 90 
per cent clottable, and when noted (35), the i/P ratio was above the 
optimum level. Half-lives of k8 to 66 hours were given but again 
distribution and fluxes cannot be calculated.
These criticisms do not apply to the recent study of A.S. 
McFarlane (^4-6), but his work was concerned with the level of 
iodination of fibrinogen, and not, except indirectly, with defining 
the behavior of fibrinogen in healthy animals.
Models Describing the Behavior of Fibrinogen
Studies with tracer-labeled fibrinogen can only be interpre 
vith the aid of a satisfactory model of the biological behavior of 
fibrinogen. Up to novr, though models for albumin metabolism and
■h***n described (113) (U2*), no studies have been distribution have been descriDeu
rnug studies described here made of the fibrinogen-fibrin system. The stun
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have permitted the development of such a model. The increase in 
knowledge of albumin metabolism and distribution has depended largely 
on the development of models which describe its behavior and the 
same should be true for fibrinogen.
The Fluxes and Distribution of Fibrinogen in Healthy Young and Older 
Rabbits
The data of Tables XI and XII provide normal values for young 
and older rabbits. Of interest are the more rapid transcapillary 
and catabolic fluxes found in the young rabbits. Thus, the mean 
transcapillary flux in the young rabbits was 171 mg/kg/day compared 
to 81 mg/kg/day in the older rabbits. The mean catabolic flux in 
the young rabbits was 56.5 mg/kg/day compared to 39 mg/kg/day in the 
older rabbits. A possible explanation is that greater activity in 
the young animals, or perhaps greater porosity or pinocytosis in 
the capillary endothelium, is responsible for the increased trans­
capillary flux. A possible explanation for the increased catabolic 
flux is greater utilization of fibrinogen during growth. Both these 
explanations require experimental demonstration.
Significance of the Finding for j^ brinogSS Catabolign
The possible mechanisms underlying the first order tracer 
constants have already heen discussed. Here it is noted that the 
findings on cataholism of ^-fibrinogen, namely that this is a 
first order process, and that catabolic of ^.fibrinogen leaving 
the plasma occurs vithout observable delay, »ould fit a current 
theory of fibrinogen breaMown. This theory, championed by
Copley (29), holds that fibrinogen is continually deposited
9k
on the vascular endothelium and continually broken down by 
fibrinolysis. If the fibrinolytic enzyme is unsaturated by its 
fibrin substrate this picture would explain the findings. Other 
mechanisms of fibrinogen catabolism must occur in disease, for 
instance during inflammation, which may resemble more closely the 
events that occur after subcutaneous formation of I13 -fibrin blood
clots.
These mechanisms require further study.
SUMMARY
The object of this study was to define the behavior of r*'3*'- 
fibrinogen and fibrinogen in healthy rabbits. Rabbit fibrinogen 
of high clottability was first prepared by ammonium sulfate fraction- 
action and its purity was examined with starch gel zone and moving 
boundary electrophoresis. The purified fibrinogen was then labeled 
with I^^-iodine and the permissible level of iodination was 
established at 0.5 atom of iodine per molecule of fibrinogen by 
"biological screening". Above this level of iodination the in vivo 
behavior of the I131-fibrinogen did not reflect the behavior of 
native fibrinogen. Standard methods of measuring fibrinogen con- 
centration were tested end found to be inaccurate. An isotope dilution 
method for measuring the plasma fihrinogen concentration was therefore 
developed. On test this method gave accurate measurements ofplasma 
fibrinogen concentration. Studies of the behavior of the I 
fibrinogen after intravenous injection were made in 7 older and 9 
young rabbits. The angels were studied for 8 to 10 days and the 
following measurements were made: the pla^a fibr^ogen concentration,
the plasma ^ -fibrinogen and I131 unbound to protein and the 
urinary a*d fecal excretion of radioactivity. The disappearance of 
^-fibrinogen **. the plasma was described by a 3 or 3 e^onentral
4- imrvwl edge models of fi*bnnogen equation. On the basis of present Knowledge m
151 . . were advanced. These models wereand -fibrinogen behavior were
» — » -  — -  “ *•“  -
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and equations were developed to describe them. Using these 
equations, the fractional rates of I131-fihrinogen transcapillary 
passage, and catabolism were calculated, and from these the fluxes 
of fibrinogen into the interstitial fluids and to catabolic sites 
were calculated. The transcapillary flux averaged 171 mg/kg/day 
in the young rabbits and 8l mg/kg/day in the older. The 
fibrinogen catabolic flux averaged 56.5 and 39 mg/kg/day in the 
young and older rabbits respectively. The equations of the model 
allow calculation of the total interstitial to plasma fibrinogen 
ratio. This averaged 0.20 and O.36 in the older and young animals 
respectively. In the older animals the total plasma fibrinogen per 
kilogram bodyweight averaged 106 mg and the total interstitial 
fibrinogen per kilogram bodyweight 22 mg. In the young animals the
values were ll8 mg and b2 mg respectively.
The studies show that the I131-fibrinogen system behaves either 
as an unsaturated or a volumetric clearance system with respect to 
transcapillary passage and fibrinogen catabolism. The physiological 
significance of this is examined.
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